By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
DailynewsegyptDailynewsegypt
  • Home
  • Business
    BusinessShow More
    The meeting witnessed an exchange of views and visions of the two countries regarding political and security developments and interactions in the Horn of Africa and the Red Sea regions.
    Egypt, Japan discuss security issues in Horn of Africa, Red Sea
    March 22, 2023
    $150 increase in gold prices since Silicon Valley Bank crisis: Gold Bullion
    $150 increase in gold prices since Silicon Valley Bank crisis: Gold Bullion
    March 22, 2023
    Environment Minister launches country report for climate and development
    Environment Minister launches country report for climate and development
    March 22, 2023
    Robert F Kennedy on the presidential campaign trail in 1968, as he talked about limitations of gross domestic product* (GDP). Alamy
    Beyond GDP: Changing how we measure progress is key to tackling a world in crisis
    March 21, 2023
    IMF reaches staff-level deal with Somalia
    IMF reaches staff-level deal with Somalia
    March 21, 2023
  • Politics
    PoliticsShow More
    Al Azhar University partners with Google to empower students with latest learning solutions
    Al Azhar University partners with Google to empower students with latest learning solutions
    March 22, 2023
    Irrigation Minister discusses international cooperation with UNGA President
    Irrigation Minister discusses international cooperation with UNGA President 
    March 22, 2023
    Luxor hosts conference on climate change: Shoukry
    Luxor to host conference on climate change: Shoukry
    March 22, 2023
    Arab League condemns Israeli minister who denies historical rights of Palestinians
    Arab League condemns Israeli minister who denies historical rights of Palestinians
    March 22, 2023
    New York beefs up security measures amid uncertainties over Trump case
    New York beefs up security measures amid uncertainties over Trump case
    March 22, 2023
  • Interviews
    InterviewsShow More
    Government should help Egyptian arts revive its pioneering role: Omar Abdel Aziz
    Government should help Egyptian arts revive its pioneering role: Omar Abdel Aziz
    March 15, 2023
    Interconnected healthcare systems in Africa require political will from North African leaders: Amref official
    Interconnected healthcare systems in Africa require political will from North African leaders: Amref official
    March 12, 2023
    EGX ready for government’s IPOs programme: Chairperson
    EGX ready for government’s IPOs programme: Chairperson
    February 15, 2023
    British International Investment invests $4.5bn in 700 businesses across Africa: Sherine Shohdy
    February 15, 2023
    Valeo has invested around €0.5bn in Egypt over the past 10 years: CEO
    Valeo has invested around €0.5bn in Egypt over the past 10 years: CEO
    December 27, 2022
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Reading: New Innovative treatment for patients with moderate-to-severe Atopic Dermatitis, severe Asthma
Share
Notification
Latest News
The meeting witnessed an exchange of views and visions of the two countries regarding political and security developments and interactions in the Horn of Africa and the Red Sea regions.
Egypt, Japan discuss security issues in Horn of Africa, Red Sea
Business
$150 increase in gold prices since Silicon Valley Bank crisis: Gold Bullion
$150 increase in gold prices since Silicon Valley Bank crisis: Gold Bullion
Business
Al Azhar University partners with Google to empower students with latest learning solutions
Al Azhar University partners with Google to empower students with latest learning solutions
Politics Egypt
Irrigation Minister discusses international cooperation with UNGA President
Irrigation Minister discusses international cooperation with UNGA President 
Egypt Politics
Luxor hosts conference on climate change: Shoukry
Luxor to host conference on climate change: Shoukry
Politics Egypt
Aa
Aa
DailynewsegyptDailynewsegypt
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Have an existing account? Sign In
Follow US
  • Advertise
© 2023 DNE News. All Rights Reserved.
Dailynewsegypt > Blog > Business > New Innovative treatment for patients with moderate-to-severe Atopic Dermatitis, severe Asthma
Business

New Innovative treatment for patients with moderate-to-severe Atopic Dermatitis, severe Asthma

Daily News Egypt
Last updated: 2021/08/04 at 12:45 PM
By Daily News Egypt 7 Min Read
Share
New Innovative treatment for patients with moderate-to-severe Atopic Dermatitis, severe Asthma
SHARE

The Egyptian Drug Authority (EDA) approved last April Dupixent (dupilumab) for medical use in adults and adolescents for two chronic diseases. Sanofi Egypt launched Dupixent at a press conference on Sunday.

Dupixent is a treatment to moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable

It is also an add-on maintenance treatment for severe asthma with type 2 inflammation.

Atopic dermatitis is a chronic inflammatory disease that often appears as a rash on the skin. Moderate-to-severe atopic dermatitis is characterized by rashes that can potentially cover much of the body, and can include intense, persistent itching, skin dryness and skin lesions including cracking, redness or darkness, crusting and oozing. Itch is one of the most burdensome symptoms for patients and can be debilitating. Inadequately controlled atopic dermatitis can have a physical, emotional and psychosocial impact, causing sleep disturbance, symptoms of anxiety and depression, and feelings of isolation.

“According to recent research, AD affected 171 million people in 2019(8). 15-20% of children (9) and 1-3% of adults,” said Professor Dr. Assem Farag – Professor of Dermatology and Venereology- Chairman of Sharm Derma Academy

The limited treatment options in Egypt for moderate-to-severe atopic dermatitis has left many patients and those who care for them coping with the physical and emotional burden of the disease,

“We support timely access to this important new medication for those with moderate-to-severe atopic dermatitis to help them control and provide relief for this life-altering, often severely debilitating, chronic disease,” Farag said.

He added, “Sometimes conventional medicine is unable to provide a radical solution to some skin diseases. The currently used therapeutic protocols only give the patient some local comfort through the use of some types of unsafe medicines for long-term use (some types of creams or ointments that contain corticosteroids, antibiotics, and drugs that suppress the functioning of the immune system). They may cause some serious side effects such as stunted growth, weakened immune system, and other problems. For this reason, these medicines are given for periods they are limited and only in severe infections. Also, given that the genetic causes of Atopic Dermatitis are still not fully understood yet, conventional treatments may provide limited and only temporary control over the symptoms of the disease, but they are unable – unfortunately – to provide a radical solution to this disease.”

Dupixent is a fully-human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins, and is not an immunosuppressant. IL-4 and IL-13 are key and central drivers of the type 2 inflammation that plays a major role in atopic dermatitis and asthma.

“Globally, one out of 10 persons(11) is affected with AD and the prevalence rate is highest in early childhood. ” said Professor Dr. Mahira Hamdy El Sayed Professor of Dermatology & Venereology at Ain Shams University, Head of Egyptian Society of Dermatology.

 In Egypt, DUPIXENT is indicated for the treatment of patients aged 12 and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent is the only biologic medicine approved for this patient population.

Asthma is a chronic lung disease caused by the interaction of genetic and environmental factors. It causes airways to narrow and swell and produce mucus. The main symptoms are coughing, wheezing, shortness of breath but severe asthma attacks can even lead to hospitalization. Currently, there is no cure for asthma and treatments available are used to control the symptoms (reliever) or to reduce the frequency and severity of the attacks (controller).

“According to the WHO, asthma affected an estimated 262 million people in 2019 and caused 461000 deaths (12),” said Professor Dr. Adel Khattab Professor of Pulmonary Medicine, Ain Shams University- Vice President of Egyptian Scientific Society of Bronchology.

People whose severe asthma is inadequately controlled on current therapy continue to have trouble breathing and suffer potentially life-threatening exacerbations. This daily burden and unpredictability can significantly diminish quality of life, causing missed days of school, work and social activities,”  “We, as physicians,  welcome the addition of new treatments such as Dupixent, designed to help those with severe asthma take control of their symptoms and get on with their daily lives.”

“Type 2 inflammation is responsible for many of the hallmark symptoms of asthma – and Dupixent is the first and only biological treatment approved for patients in Egypt with severe asthma characterized by multiple biomarkers of type 2 inflammation,” said Professor Dr. Gihan El-Assal Professor of Pulmonary Medicine, Ain Shams University.

She added, “Dupixent not only reduced exacerbations and oral corticosteroid use, but it also improved lung function and patients’ overall quality of life. Dupixent offers a new treatment option for those who remain inadequately controlled with current medications, including those dependent on oral corticosteroids – which may have potentially serious side effects when used chronically.”

“Sanofi Genzyme is committed to delivering transformative therapies for Egyptian patients with special unmet medical needs with innovative products furthermore providing hope where there was none before. That’s why Dupixent (dupilumab) is considered a new hope for patients and one of the recent innovative medical treatments offered by Sanofi Genzyme for patients with moderate-to-severe Atopic Dermatitis and severe Asthma,” said Ahmed Hegazy General Manager Sanofi Genzyme in Egypt and Sudan

He added that Dupixent (dupilumab) has been successfully launched in 60 countries all over the world. Its launch in Egypt is a cornerstone for treating patients with asthma and atopic dermatitis.

You Might Also Like

Egypt, Japan discuss security issues in Horn of Africa, Red Sea

$150 increase in gold prices since Silicon Valley Bank crisis: Gold Bullion

Environment Minister launches country report for climate and development

Beyond GDP: Changing how we measure progress is key to tackling a world in crisis

IMF reaches staff-level deal with Somalia

TAGGED: Atopic Dermatitis
Share this Article
Facebook Twitter Email Print
Previous Article NATCO appoints Beltone as financial advisor to EGP 1bn bond issuance
Next Article Agricultural Bank offers soft loans for small milk producers with 5% diminishing interest
Ad image

Stay Connected

Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe

Latest News

The meeting witnessed an exchange of views and visions of the two countries regarding political and security developments and interactions in the Horn of Africa and the Red Sea regions.
Egypt, Japan discuss security issues in Horn of Africa, Red Sea
Business
$150 increase in gold prices since Silicon Valley Bank crisis: Gold Bullion
$150 increase in gold prices since Silicon Valley Bank crisis: Gold Bullion
Business
Al Azhar University partners with Google to empower students with latest learning solutions
Al Azhar University partners with Google to empower students with latest learning solutions
Politics Egypt
Irrigation Minister discusses international cooperation with UNGA President
Irrigation Minister discusses international cooperation with UNGA President 
Egypt Politics
//
Egypt’s only independent daily newspaper in English. Discuss the country’s latest with the paper’s reporters, editors, and other readers.

Quick Link

  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

© 2023 DNE News. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?